By action from September 1st 2010, the basic and clinically aiming research associated with the monoclonal autoantibody IC2 and its unique autoantigen specific on the surface of the pancreatic beta-cell, will move from University of Copenhagen, Department of Biomedical Sciences, to the new and modern Copenhagen Biocenter,  and be part of The Bartholin Institute, which is a research unit under the University Hospital, Rigshospitalet with a long track of research in autoimmune diabetes and pathology..

The Bartholin Institut home excellent fascilities for flow cytometric analysis, confocal laser microscopy, cell biology, histochemistry, immunocytochemistry, immunology, immunochemistry plus molecular biology. We look forward to a fruitful collaboration.